Skip to main content
SpringerLink
Log in

Classification, Diagnosis and Treatment of Vascular Dementia

  • Review Article
  • Disease Management
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Summary

Vascular dementia (VAD) is considered to be the second most common cause of dementia in Europe and the US. In Asia and many developing countries, it is more common than dementia of the Alzheimer’s type (DAT). VAD is the most preventable form of dementia associated with later life. The pathogenesis of VAD is multifactorial, and it represents a heterogeneous, not a homogeneous, clinical entity. Classification of VAD by pathogenesis is important for its prevention and treatment. Control of the risk factors for VAD reduces its incidence and stabilises or improves cognitive performance following stroke.

Proper diagnostic evaluation of VAD requires: (i) a well defined quantitative assessment of the cognitive deficits present; (ii) assessment of risk factors for stroke; (iii) identification of cerebral vascular lesions by history, neurological examination and neuroimaging; (iv) exclusion of other causes of dementia;(?) establishment of a positive diagnosis of possible, probable or definite VAD versus DAT or mixed VAD/DAT; and (vi) identification of the temporal relationship between cognitive deficits and cerebral vascular lesions.

VAD can be subdivided into 8 major types, as follows: (i) multi-infarct dementia secondary to large cerebral emboli [type 1]; (ii) strategically placed infarctions causing dementia [type 2]; (iii) multiple subcortical lacunar lesions secondary to atherosclerosis or degenerative arteriolar changes [type 3]; (iv) Binswanger’s disease (arteriosclerotic subcortical leukoencephalopathy) [type 4]; (v) mixtures of types 1, 2 and 3 [type 5]; (vi) haemorrhagic lesions causing dementia [type 6]; (vii) subcortical dementia secondary to hereditary factors (type 7); and (viii) mixtures of DAT and VAD (type 8). Treatment is dictated by the pathogenetic subtype of VAD that is present.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Tomlinson BE, Blessed G, Roth M. Observations of the brains of demented old people. J Neurol Sci 1970; 11: 205–42

    Article  PubMed  CAS  Google Scholar 

  2. Jellinger K. Neuropathological aspects of dementias resulting from abnormal blood and cerebrospinal fluid dynamics. Acta Neurol Belg 1976; 76: 83–102

    PubMed  CAS  Google Scholar 

  3. Schoenberg BS. Epidemiology of vascular dementia and multiinfarct dementia. In: Meyer JS, Lechner H, Marshall J, et al., editors. Vascular and multi-infarct dementia. Mt Kisco (NY): Futura Publishing Co., 1988: 47–59

    Google Scholar 

  4. Ueda K, Hasuo Y, Fujishima M. Prevalence and etiology of dementia in a Japanese community. Stroke 1992; 23: 798–803

    Article  PubMed  CAS  Google Scholar 

  5. Yoshitake T, Kiyohara Y, Kato I, et al. Incidence and risk factor of vascular dementia and Alzheimer’s disease in a defined elderly Japanese population. Neurology 1995; 45: 1161–8

    Article  PubMed  CAS  Google Scholar 

  6. Skoog I, Nilsson L, Palmertz B, et al. A population-based study of dementia in 85-year-olds. N Engl J Med 1993; 328: 153–8

    Article  PubMed  CAS  Google Scholar 

  7. Meyer JS, Judd BW, Tawaklna T, et al. Improved cognition after control of risk factors for multi-infarct dementia. JAMA 1986; 256: 2203–9

    Article  PubMed  CAS  Google Scholar 

  8. Meyer JS, McClintic K, Sims P, et al. Etiology, prevention, and treatment of vascular and multi-infarct dementia. In: Meyer JS, Lechner H, Marshall J, et al., editors. Vascular and multi-infarct dementia. Mt Kisco (NY): Futura Publishing Co., 1988: 129–47

    Google Scholar 

  9. Meyer JS, Rogers RL, McClintic K, et al. Randomized clinical trial of daily aspirin therapy in multi-infarct dementia. J Am Geriatr Soc 1989; 37: 549–55

    PubMed  CAS  Google Scholar 

  10. Meyer JS. Differential diagnosis, etiology, pathophysiology and treatment of multi-infarct dementia. Recent Adv Cardiovasc Dis 1990; 11 Suppl. 1: 83–9

    Google Scholar 

  11. Meyer JS, Muramatsu K, Mortel KF, et al. Prospective CT confirms differences between vascular and Alzheimer’s dementia. Stroke 1995; 26: 735–42

    Article  PubMed  CAS  Google Scholar 

  12. Hachinski VC. Preventable senility: a call for action against the vascular dementias. Lancet 1992; 340: 645–8

    Article  PubMed  CAS  Google Scholar 

  13. Loeb C, Meyer JS. Vascular dementia: still a debatable entity? J Neurol Sci 1996; 143: 31–40

    Article  PubMed  CAS  Google Scholar 

  14. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994

    Google Scholar 

  15. WHO. International statistical classification of related health problems, 10th revision (ICD-10). Geneva: WHO, 1992

    Google Scholar 

  16. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology 1993; 43: 250–60

    Article  PubMed  CAS  Google Scholar 

  17. Chui HC, Victoroff JI, Margolin D, et al. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer’s Disease Diagnostic and Treatment Centers. Neurology 1992; 42: 473–80

    Article  PubMed  CAS  Google Scholar 

  18. Desmond DW. Vascular dementia: a construct in evolution. Cerebrovasc Brain Metab Rev 1996; 8: 296–325

    PubMed  CAS  Google Scholar 

  19. Tatemichi TK, Desmond DW, Mayeux R, et al. Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology 1992; 42: 1185–93

    Article  PubMed  CAS  Google Scholar 

  20. Meyer JS, McClintic KL, Rogers RL, et al. Aetiological considerations and risk factors for multi-infarct dementia. J Neurol Neurosurg Psychiatry 1988; 51: 1489–97

    Article  PubMed  CAS  Google Scholar 

  21. Skoog I. Risk factors for vascular dementia: a review. Dementia 1994; 5: 137–44

    PubMed  CAS  Google Scholar 

  22. Lindsay J, Hébert R, Rockwood K. The Canadian Study of Health and Aging: risk factors for vascular dementia. Stroke 1997; 28: 526–30

    Article  PubMed  CAS  Google Scholar 

  23. Johansson BB. Pathogenesis of vascular dementia: the possible role of hypertension. Dementia 1994; 5: 174–6

    PubMed  CAS  Google Scholar 

  24. Desmond DW, Tatemichi TK, Paik M, et al. Risk factors for cerebrovascular disease as correlates of cognitive function in a stroke-free cohort. Arch Neurol 1993; 50: 162–6

    Article  PubMed  CAS  Google Scholar 

  25. Tatemichi TK, Desmond DW, Paik M, et al. Clinical determinants of dementia related to stroke. Ann Neurol 1993; 33: 568–75

    Article  PubMed  CAS  Google Scholar 

  26. Ott A, Breteler MMB, Bruyne MC, et al. Atrial fibrillation and dementia in a population-based study: the Rotterdam Study. Stroke 1997; 28: 316–21

    Article  PubMed  CAS  Google Scholar 

  27. Gorelick PB, Brody J, Cohen D, et al. Risk factors for dementia associated with multiple cerebral infarcts: a case-control analysis in predominantly African-American hospital-based patients. Arch Neurol 1993; 50: 714–20

    Article  PubMed  CAS  Google Scholar 

  28. Rockwood K, Ebly E, Hachinski V, et al. Presence and treatment of vascular risk factors in patients with vascular cognitive impairment. Arch Neurol 1997; 54: 33–9

    Article  PubMed  CAS  Google Scholar 

  29. Tatemichi TK, Paik M, Bagiella MS, et al. Risk of dementia after stroke in a hospitalized cohort: result of a longitudinal study. Neurology 1994; 44: 1885–91

    Article  PubMed  CAS  Google Scholar 

  30. Mortel KF, Meyer JS, Herod B, et al. Education and occupation as risk factors for dementias of the Alzheimer and ischemic vascular types. Dementia 1995; 6: 55–62

    PubMed  CAS  Google Scholar 

  31. Gorelick PB. Status of risk factors for dementia associated with stroke. Stroke 1997; 28: 459–63

    Article  PubMed  CAS  Google Scholar 

  32. Plassman BL, Breitner CS. Recent advances in the genetics of Alzheimer’s disease and vascular dementia with an emphasis on gene-environment interactions. J Am Geriatr Soc 1996; 44: 1242–50

    PubMed  CAS  Google Scholar 

  33. Moroney JT, Bagiella E, Desmond DW, et al. Risk factors for incident dementia after stroke: role of hypoxic and ischemic disorders. Stroke 1996; 27: 1283–9

    Article  PubMed  CAS  Google Scholar 

  34. Mortel KF, Meyer JS. Lack of postmenopausal estrogen replacement therapy and the risk of dementia. J Neuropsychiatry Clin Neurosci 1995; 7: 334–7

    PubMed  CAS  Google Scholar 

  35. Meyer JS, Rogers RL, Judd BW, et al. Cognition and cerebral blood fluctuate together in multi-infarct dementia. Stroke 1988; 19: 163–9

    Article  PubMed  CAS  Google Scholar 

  36. Meyer JS. The nature of reduced cerebral perfusion in vascular and multi-infarct dementia. In: Meyer JS, Lechner H, Marshall J, editors. Vascular and multi-infarct dementia. Mt Kisco (NY): Futura Publishing Co., 1988: 113–27

    Google Scholar 

  37. Loeb C. Vascular dementia. Dementia 1990; 1: 175–84

    Google Scholar 

  38. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 1984; 34: 939–44

    Article  PubMed  CAS  Google Scholar 

  39. Hachinski VC, Iliff LD, Zilhka E, et al. Cerebral blood flow in dementia. Arch Neurol 1975; 32: 632–7

    Article  PubMed  CAS  Google Scholar 

  40. O’Brien MD. Vascular dementia is underdiagnosed. Arch Neurol 1988; 45: 797–8

    Article  PubMed  Google Scholar 

  41. Blacker D, Albert MS, Bassett SS, et al. Reliability and validity of NINCDS-ADRDA criteria for Alzheimer’s disease: the National Institute of Mental Health Genetics Initiative. Arch Neurol 1994; 51: 1198–204

    Article  PubMed  CAS  Google Scholar 

  42. Erkinjuntti T. Clinical criteria for vascular dementia: the NINDS-AIREN criteria. Dementia 1994; 5: 189–92

    PubMed  CAS  Google Scholar 

  43. Tierney MC, Fisher RH, Lewis AJ, et al. The NINCDS-ADRDA work group criteria for clinical diagnosis of probable Alzheimer’s disease: a clinicopathologic study of 57 cases. Neurology 1988; 38: 359–64

    Article  PubMed  CAS  Google Scholar 

  44. Erkinjuntti T. Accuracy of the clinical diagnosis of vascular dementia: a prospective clinical and post-mortem neuropathological study. J Neurol Neurosurg Psychiatry 1988; 51: 1037–44

    Article  PubMed  CAS  Google Scholar 

  45. Kukull WA, Larson EB, Reifler BV, et al. The validity of three clinical diagnostic criteria for Alzheimer’s disease. Neurology 1990; 40: 1364–89

    Article  PubMed  CAS  Google Scholar 

  46. Risse SC, Raskind MA, Nochlin D. Neuropathological findings in patients with clinical diagnoses of probable Alzheimer’s disease. Am J Psychiatry 1990; 147: 168–72

    PubMed  CAS  Google Scholar 

  47. Jellinger K, Danielczyk W, Fischer P, et al. Clinicopathological analysis of dementia disorders in the elderly. J Neurol Sci 1990; 95: 239–58

    Article  PubMed  CAS  Google Scholar 

  48. Lopez OL, Larumbe MR, Becker JT, et al. Reliability of NINDS-AIREN clinical criteria for the diagnosis of vascular dementia. Neurology 1994; 44: 1240–5

    Article  PubMed  CAS  Google Scholar 

  49. Wetterling T, Kanitz RD, Borgis KJ. Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN). Stroke 1996; 27: 30–6

    Article  PubMed  CAS  Google Scholar 

  50. Wade JPH, Mirsen TR, Hachinski VC, et al. The clinical diagnosis of Alzheimer’s disease. Arch Neurol 1987; 44: 24–9

    Article  PubMed  CAS  Google Scholar 

  51. O’Brien MD. Vascular dementia: problems with nomenclature, definition, and classification. J Stroke Cerebrovasc Dis 1994; 4: 52–6

    Article  Google Scholar 

  52. Wallin A, Blennow K. The clinical diagnosis of vascular dementia. Dementia 1994; 5: 181–4

    PubMed  CAS  Google Scholar 

  53. Brun A. Pathology and pathophysiology of cerebrovascular dementia: pure subgroups of obstructive and hypoperfusive etiology. Dementia 1994; 5: 145–7

    PubMed  CAS  Google Scholar 

  54. Meyer JS, Shirai T, Akiyama H. Vascular dementia. In: Welch KMA, Caplan L, Reis D, et al., editors. Primer on cerebrovascular disease. San Diego: Academic Press Inc., 1997: 364–6

    Chapter  Google Scholar 

  55. Tatemichi TK. How acute brain failure becomes chronic: a view of the mechanisms of dementia related to stroke. Neurology 1990; 40: 1652–9

    Article  PubMed  CAS  Google Scholar 

  56. Loeb C, Gandolfo C, Croce R, et al. Dementia associated with lacunar infarction. Stroke 1992; 23: 1225–9

    Article  PubMed  CAS  Google Scholar 

  57. Roman GC. From UBOs to Binswanger’s disease: impact of magnetic resonance imaging on vascular dementia research. Stroke 1996; 27: 1269–73

    Article  PubMed  CAS  Google Scholar 

  58. Caplan LR. Binswanger’s disease — revisited. Neurology 1995; 45: 626–33

    Article  PubMed  CAS  Google Scholar 

  59. Tournier-Lasserve E, Iba-Zizen MT, Romero N, et al. Autosomal dominant syndrome with strokelike episodes and leukoencephalopathy. Stroke 1991; 22: 1297–302

    Article  PubMed  CAS  Google Scholar 

  60. Bousser MG, Tournier-Lasserve E. Summary of the proceedings of the first international workshop on CADASIL: Paris, May 19–21, 1993. Stroke 1994; 25: 704–5

    Article  PubMed  CAS  Google Scholar 

  61. You R, McNeil JJ, O’Malley HM, et al. Risk factors for lacunar infarction syndromes. Neurology 1995; 45: 1483–7

    Article  PubMed  CAS  Google Scholar 

  62. Skoog I, Lernfelt B, Landahl S, et al. 15-Year longitudinal study of blood pressure and dementia. Lancet 1996; 347: 1141–5

    Article  PubMed  CAS  Google Scholar 

  63. Shaw TG, Mortel KF, Meyer JS, et al. Cerebral blood flow changes in benign aging and cerebrovascular disease. Neurology 1984; 34: 855–62

    Article  PubMed  CAS  Google Scholar 

  64. Masawa N, Yoshida Y, Yamada T, et al. Morphometry of structural preservation of tunica media in aged and hypertensive human intracerebral arteries. Stroke 1994; 25: 122–7

    Article  PubMed  CAS  Google Scholar 

  65. Watanabe N, Imai Y, Nagai K, et al. Nocturnal blood pressure and silent cerebrovascular lesions in elderly Japanese. Stroke 1996; 27: 1319–27

    Article  PubMed  CAS  Google Scholar 

  66. Meyer JS, Muramatsu K, Shirai T, et al. Cerebral embolism as a cause of stroke and transient ischemic attacks. Echocardiography 1996; 13: 513–7

    Article  Google Scholar 

  67. Stroke Prevention in Atrial Fibrillation Investigators. Stroke prevention in atrial fibrillation study: final results. Circulation 1991; 84: 527–34

    Article  Google Scholar 

  68. Stroke Prevention in Atrial Fibrillation Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet 1994; 343: 687–91

    Google Scholar 

  69. Van Bergen PFMM, Jonker JJC, van der Meer FJM, et al., and the Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis (ASPECT) Research Group. Effect of long-term anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction. Lancet 1994; 343: 499–503

    Google Scholar 

  70. Smith P, Amesen H, Holme I. The effect of warfarin on mortality and reinfarction after myocardial infarction. N Engl J Med 1990; 323: 147–52

    Article  PubMed  CAS  Google Scholar 

  71. Azar AJ, Koudstaal PJ, Wintzen AR, et al. Risk of stroke during long-term anticoagulant therapy in patients after myocardial infarction. Ann Neurol 1996; 39: 301–7

    Article  PubMed  CAS  Google Scholar 

  72. Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973–5

    Article  PubMed  CAS  Google Scholar 

  73. Kistler JP, Buonanno FS, Gress DR. Carotid endarterectomy: specific therapy based on pathophysiology. N Engl J Med 1991; 325: 505–7

    Article  PubMed  CAS  Google Scholar 

  74. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991; 325: 445–53

    Article  Google Scholar 

  75. Desmond DW, Moroney JT, Sano M, et al. Recovery of cognitive function after stroke. Stroke 1996; 27: 1798–803

    Article  PubMed  CAS  Google Scholar 

  76. Wolf PA. Cigarettes, alcohol and stroke. N Engl J Med 1986; 315: 1087–9

    Article  PubMed  CAS  Google Scholar 

  77. Gorelick PB, Rodin MB, Langenberg P, et al. Weekly alcohol consumption, cigarette smoking, and the risk of ischemic stroke: results of a case-control study at three urban medical centers in Chicago, Illinois. Neurology 1989; 39: 339–43

    Article  PubMed  CAS  Google Scholar 

  78. Rogers RL, Meyer JS, Shaw TG, et al. Cigarette smoking decreases cerebral blood flow suggesting increased risk for stroke. JAMA 1983; 250: 2796–800

    Article  PubMed  CAS  Google Scholar 

  79. Rogers RL, Meyer JS, Judd BW, et al. Abstention from cigarette smoking improves cerebral perfusion among elderly chronic smokers. JAMA 1985; 253: 2970–4

    Article  PubMed  CAS  Google Scholar 

  80. Birge SJ. Is there a role for estrogen replacement therapy in the prevention and treatment of dementia? J Am Geriatr Soc 1996; 44: 865–70

    PubMed  CAS  Google Scholar 

  81. Hass WK, Easton JD, Adams HP, et al., for the Ticlopidine Aspirin Stroke Study Group. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 1989; 321: 501–7

    Article  PubMed  CAS  Google Scholar 

  82. Black RS, Barclay LL, Nolan KA, et al. Pentoxifylline in cerebrovascular dementia. J Am Geriatr Soc 1992; 40: 237–44

    PubMed  CAS  Google Scholar 

  83. Molnar FJ, Dalziel WB. The pharmacoeconomics of dementia therapies. Drugs Aging 1997 Mar; 10(3): 219–33

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Baylor College of Medicine, Cerebrovascular Research Laboratories, Houston, Texas, USA

    Shizuko Konno,  John Stirling Meyer (Director), Yasuo Terayama, Gaiane M. Margishvili & Karl F. Mortel

Authors
  1. Shizuko Konno
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John Stirling Meyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yasuo Terayama
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gaiane M. Margishvili
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Karl F. Mortel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John Stirling Meyer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Konno, S., Meyer, J.S., Terayama, Y. et al. Classification, Diagnosis and Treatment of Vascular Dementia. Drugs & Aging 11, 361–373 (1997). https://doi.org/10.2165/00002512-199711050-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-199711050-00004

Search

Navigation